Carboplatin increases efficacy of paclitaxel/trastuzumab in breast cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1375, 2003-01, pp. : 13-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A regimen of trastuzumab, paclitaxel, carboplatin and gemcitabine has favourable efficacy in advanced, HER2-positive urothelial cancer

Inpharma, Vol. 1, Iss. 1591, 2007-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

First-line therapy with trastuzumab plus paclitaxel and carboplatin may be active in patients with HER-2 over-expressing metastatic breast cancer

Inpharma, Vol. 1, Iss. 1441, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Gemcitabine boosts paclitaxel efficacy in metastatic breast cancer

Inpharma, Vol. 1, Iss. 1453, 2004-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Paclitaxel/trastuzumab: Interstitial pneumonitis: case report

Reactions Weekly, Vol. 1, Iss. 1359, 2011-01 ,pp. : 29-30

Adis International

Access to resources Recommend Favorite

Induction paclitaxel/carboplatin followed by radiotherapy and paclitaxel shows promising efficacy in unresectable non-small-cell lung cancer

Inpharma, Vol. 1, Iss. 1469, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite